Pharma Asset Strategy

Pharma Asset Strategy II

Coming Soon: This module introduces you to segmenting disease epidemiology, analyzing eligible populations, incorporating annual cost of therapies, all to build a revenue model and an asset valuation model. We start from scratch (blank sheet)!

Buy $800.00 Free Preview

Course curriculum

1. pTRS - Probability of Technical and Regulatory Success
  FREE PREVIEW
2. pTRS - BIO Paper on Success Rates
3. pTRS - MIT Paper on Success Rates
4. pTRS - MIT Paper on Success Rates, Supplemental Info
5. Chapter 1 - Review of pTRS (Full Lecture)
6. Chapter 1 - Review of pTRS (Free Preview)
  FREE PREVIEW
1. MG - Indication Analysis
  FREE PREVIEW
1. Starting from Scratch
  FREE PREVIEW
1. Annual Reports
  FREE PREVIEW
1. Layering Patient Shares and ACTs
  FREE PREVIEW
1. Model Sanity Checks
  FREE PREVIEW
1. Valuation Concepts and Terms
  FREE PREVIEW
1. Valuation - Example and Model Construct
  FREE PREVIEW
1. Building the Valuation Model
  FREE PREVIEW
1. Revenue + Valuation Models
  FREE PREVIEW

About this course

$800.00
15 lessons
0 hours of video content

Discover your potential, starting today

Enroll today

PrimerProf

Pharma Asset Strategy II

Course curriculum

Chapter 1 - Forecasting Basics: Review of pTRS

Chapter 2 - Case Example: Myasthenia Gravis

Chapter 3 - Forecasting: Initial Build

Chapter 4 - Analyzing Annual Reports

Chapter 5 - Forecasting: Layering in Annual Cost of Therapies

Chapter 6 - Forecasting: Model Sanity Checks

Chapter 7 - Valuation Basics: Concepts and Terms

Chapter 8 - Valuation: Model Construct and Adding in Costs

Chapter 9 - Valuation: Free Cash Flows, NPV Ranges and Enterprise Value

Chapter 10 - Composite Forecast and Valuation Models: Sanity Checks

About this course

Discover your potential, starting today